Treatment outcomes in drug resistant juvenile myoclonic epilepsy: valproate resistance may not be the end of the road

To determine treatment responses to various antiseizure medicines (ASMs) in patients with drug resistant juvenile myoclonic epilepsy (DRJME)
Source: Seizure: European Journal of Epilepsy - Category: Neurology Authors: Source Type: research
More News: Epilepsy | Neurology